Combined Bilateral Salpingo-oophorectomy and Cesarean Delivery in BRCA1/2 Alteration Carriers: A Case Series

被引:1
|
作者
Barker, Victoria E. [1 ,2 ]
Vlachodimitropoulou, Evangelia [1 ,2 ]
O'Brien, Patrick [1 ,2 ]
Iskaros, Joseph [1 ,2 ]
Rosenthal, Adam N. [1 ,2 ,3 ]
机构
[1] Univ Coll London Hosp, Natl Hlth Serv Fdn Trust, London, England
[2] UCL, Univ Coll London Elizabeth Garrett Anderson Inst W, Dept Womens Canc, London, England
[3] Univ Coll London Hosp NHS Fdn Trust, London, England
关键词
BREAST-CANCER; OVARIAN; RISK; WOMEN;
D O I
10.1097/AOG.0000000000005423
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: The cumulative lifetime risk of ovarian cancer is 16-68% and 11-30% in female BRCA1 and BRCA2 gene alteration carriers, respectively. Risk-reducing bilateral salpingo-oophorectomy (RRSO) is the only proven way to reduce ovarian cancer mortality. We report a series of patients who underwent risk-reducing surgery at the time of planned obstetric-indicated cesarean delivery.CASES: This is a case series of four women carrying a pathogenic germline BRCA1 or BRCA2 gene alteration who underwent RRSO at the time of cesarean delivery between March 1, 2018, and March 31, 2022. All women were referred during pregnancy to the University College London Hospitals Familial Cancer Clinic for consideration of RRSO at the time of obstetric-indicated cesarean delivery. Women were considered eligible for RRSO if they had a proven pathogenic germline alteration, would have completed childbearing after the cesarean delivery, and were older than age 35 or 40 years with BRCA1 or BRCA2 alterations, respectively. Operating time, blood loss, transfusion requirements, length of hospital stay, complications, and ability to breastfeed were assessed and, where possible, compared with the institutional means for similar patients who underwent cesarean delivery only, to determine whether RRSO was associated with increased morbidity. Women were contacted 11-59 months postprocedure to assess satisfaction. The mean blood loss was 687 mL (range 400-1,000 mL), mean operating time was 68 minutes, mean length of hospital stay was 3 days, and mean change in hemoglobin was -1 g/dL. No patient required a transfusion, had internal organ damage, returned to the operating room, or was readmitted. One of two women with intact breast tissue successfully breastfed, and the other chose to bottle feed. The mean contemporaneous institutional blood loss for cesarean delivery was not significantly different at 681 mL for singleton pregnancies and 872 mL for twin pregnancies. All four women reported a high level of satisfaction with the combined procedure.CONCLUSION: Our results show that RRSO can be performed at the time of cesarean delivery with high patient satisfaction. This approach can be offered to appropriately counseled individuals, with the benefit of avoiding the need for two separate procedures, with potentially reduced patient morbidity and health care costs.
引用
收藏
页码:1500 / 1503
页数:4
相关论文
共 50 条
  • [11] Prophylactic mastectomy and risk-Reducing salpingo-Oophorectomy in BRCA1/2 mutation carriers
    Kara N. Maxwell
    Susan M. Domchek
    Current Breast Cancer Reports, 2012, 4 (3) : 199 - 206
  • [12] Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers
    Menkiszak, Janusz
    Chudecka-Glaz, Anita
    Gronwald, Jacek
    Cymbaluk-Ploska, Aneta
    Celewicz, Aleksander
    Swiniarska, Maria
    Wezowska, Malgorzata
    Bedner, Ryszard
    Zielinska, Dorota
    Tarnowska, Paulina
    Jakubowicz, Jerzy
    Kojs, Zbigniew
    JOURNAL OF OVARIAN RESEARCH, 2016, 9
  • [13] Tubal histopathological abnormalities in BRCA1/2 mutation carriers undergoing prophylactic salpingo-oophorectomy: a case-control study
    Sina, Federica
    Cassani, Chiara
    Comerio, Chiara
    De Ponti, Elena
    Zanellini, Francesca
    Delle Marchette, Martina
    Roversi, Gaia
    Jaconi, Marta
    Arbustini, Eloisa
    Urtis, Mario
    Dell'Oro, Cristina
    Zambetti, Benedetta
    Paniga, Cristiana
    Acampora, Eleonora
    Negri, Serena
    Lazzarin, Sara
    Cesari, Stefania
    Spinillo, Arsenio
    Kotsopoulos, Joanne
    Fruscio, Robert
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (01) : 41 - 47
  • [14] Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation
    Laki, Fatima
    Kirova, Youlia M.
    This, Pascale
    Plancher, Corinne
    Asselain, Bernard
    Sastre, Xavier
    Stoppa-Lyonnet, Dominique
    Salmon, Remy
    CANCER, 2007, 109 (09) : 1784 - 1790
  • [15] Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy
    Cohen, J. V.
    Chiel, L.
    Boghossian, L.
    Jones, M.
    Stopfer, J. E.
    Powers, J.
    Rebbeck, T. R.
    Nathanson, K. L.
    Domchek, S. M.
    FAMILIAL CANCER, 2012, 11 (01) : 69 - 75
  • [16] Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy
    Fakkert, Ingrid E.
    Jansen, Liesbeth
    Meijer, Kees
    Kok, Theo
    Oosterwijk, Jan C.
    Mourits, Marian J. E.
    de Bock, Geertruida H.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (01) : 157 - 164
  • [17] Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers
    Janusz Menkiszak
    Anita Chudecka-Głaz
    Jacek Gronwald
    Aneta Cymbaluk-Płoska
    Aleksander Celewicz
    Maria Świniarska
    Małgorzata Wężowska
    Ryszard Bedner
    Dorota Zielińska
    Paulina Tarnowska
    Jerzy Jakubowicz
    Zbigniew Kojs
    Journal of Ovarian Research, 9
  • [18] Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers A Nonrandomized Controlled Trial
    Steenbeek, Miranda P.
    Harmsen, Marline G.
    Hoogerbrugge, Nicoline
    de Jong, Marieke Arts
    Maas, Angela H. E. M.
    Prins, Judith B.
    Bulten, Johan
    Teerenstra, Steven
    van Bommel, Majke H. D.
    van Doorn, Helena C.
    Mourits, Marian J. E.
    van Beurden, Marc
    Zweemer, Ronald P.
    Gaarenstroom, Katja N.
    Slangen, Brigitte F. M.
    Brood-van Zanten, Monique M. A.
    Vos, M. Caroline
    Piek, Jurgen M. J.
    van Lonkhuijzen, Luc R. C. W.
    Apperloo, Mirjam J. A.
    Coppus, Sjors F. P. J.
    Massuger, Leon F. A. G.
    IntHout, Joanna
    Hermens, Rosella P. M. G.
    de Hullu, Joanne A.
    JAMA ONCOLOGY, 2021, 7 (08) : 1203 - 1212
  • [19] Osteoporosis risk and management in BRCA1 and BRCA2 carriers who undergo risk-reducing salpingo-oophorectomy
    Garcia, Christine
    Lyon, Liisa
    Conell, Carol
    Littell, Ramey D.
    Powell, C. Bethan
    GYNECOLOGIC ONCOLOGY, 2015, 138 (03) : 723 - 726
  • [20] Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
    Mavaddat, Nasim
    Antoniou, Antonis C.
    Mooij, Thea M.
    Hooning, Maartje J.
    Heemskerk-Gerritsen, Bernadette A.
    Nogues, Catherine
    Laborde, Lilian
    Breysse, Emmanuel
    Stoppa-Lyonnet, Dominique
    Gauthier-Villars, Marion
    Buecher, Bruno
    Caron, Olivier
    Fourme-Mouret, Emmanuelle
    Fricker, Jean-Pierre
    Lasset, Christine
    Bonadona, Valerie
    Berthet, Pascaline
    Faivre, Laurence
    Luporsi, Elisabeth
    Mari, Veronique
    Gladieff, Laurence
    Gesta, Paul
    Sobol, Hagay
    Eisinger, Francois
    Nogues, Catherine
    Longy, Michel
    Dugast, Catherine
    Colas, Chrystelle
    Coupier, Isabelle
    Pujol, Pascal
    Corsini, Carole
    Lortholary, Alain
    Vennin, Philippe
    Adenis, Claude
    Nguyen, Tan Dat
    Delnatte, Capucine
    Tinat, Julie
    Tennevet, Isabelle
    Limacher, Jean-Marc
    Maugard, Christine
    Bignon, Yves-Jean
    Demange, Liliane
    Penet, Clotilde
    Dreyfus, Helene
    Cohen-Haguenauer, Odile
    Venat-Bouvet, Laurence
    Leroux, Dominique
    Zattara-Cannoni, Helene
    Fert-Ferrer, Sandra
    Bera, Odile
    BREAST CANCER RESEARCH, 2020, 22 (01)